Thomas Adams PhD

Insider Reports History

SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Thomas Adams
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Thomas Adams PhD

Form 4 holding Former Director

Cardiff Oncology, Inc.

Security class
Stock Options
Shares / value
477,870
Estimated value
$1,242,462
Report date
10 Jun 2021
Price
$2.60
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Hepion Pharmaceuticals, Inc.

Security class
Stock Options
Shares / value
291,050
Estimated value
Report date
18 May 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Thomas Adams PhD

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .